Conavi Medical Corp.
CNVIF
Clasificación en acciones
#33304
Conavi Medical Corp. is a medical technology firm that specializes in... Conavi Medical Corp. is a medical technology firm that specializes in developing, manufacturing, and commercializing advanced imaging solutions. These innovations are specifically designed to provide guidance during minimally invasive cardiovascular procedures. A notable product is the Novasight Hybrid System, which uniquely combines intravascular ultrasound (IVUS) and optical coherence tomography (OCT) into a single platform. This enables clinicians to obtain simultaneous and precisely co-registered images of the coronary arteries. Conavi Medical Corp. is headquartered in Toronto, Canada.
Precio por acción
$0.088
Capitalización bursátil
$7.51M
Cambio (1 día)
-11.65%
Cambio (1 año)
-89.24%
País
CA
Comercio Conavi Medical Corp. (CNVIF)
Categoría
Healthcare
Ratio P/B de Conavi Medical Corp. (CNVIF)
Ratio P/B al October 2026 TTM: 20.06
Según los informes financieros más recientes y el precio de las acciones de Conavi Medical Corp., el ratio P/B actual (TTM) es 20.06. Al final de 2022, el ratio P/B era -585.04.
Historial del ratio P/B de Conavi Medical Corp. desde 2007 hasta 2026
Ratio P/B al final de cada año
| Año | Ratio P/B | Cambiar |
|---|---|---|
| 2026 (TTM) | 20.06 | -43.70% |
| 2023 | 35.64 | -106.09% |
| 2022 | -585.04 | -1,300.42% |
| 2021 | 48.74 | -123.59% |
| 2020 | -206.59 | 531.03% |
| 2019 | -32.74 | -126.81% |
| 2018 | 122.13 | -31.89% |
| 2017 | 179.31 | -87.76% |
| 2016 | 1.47K | -130.78% |
| 2015 | -4.76K | -5,081.41% |
| 2014 | 95.57 | -87.72% |
| 2013 | 778.02 | 86.70% |
| 2012 | 416.73 | 112.61% |
| 2011 | 196.01 | 18.27% |
| 2010 | 165.73 | 55.49% |
| 2009 | 106.59 | 30.66% |
| 2008 | 81.57 | -89.18% |
| 2007 | 753.59 | 0.00% |
Ratio P/B de empresas similares o competidoras
| Empresa | Ratio P/B | Diferencia del ratio P/B | País |
|---|---|---|---|
| 3.5116 | -82.50% |
US
|
|
| 2.0146 | -89.96% |
IE
|
|
| 4.5025 | -77.56% |
US
|
|
| 2.5486 | -87.30% |
US
|
|
| - | - |
DE
|
